| 8 -0.77 (-8.78%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.05 | 1-year : | 15.75 |
| Resists | First : | 11.17 | Second : | 13.48 |
| Pivot price | 8.56 |
|||
| Supports | First : | 7.44 | Second : | 6.19 |
| MAs | MA(5) : | 8.53  |
MA(20) : | 9.44 |
| MA(100) : | 9.1 |
MA(250) : | 6.54 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 25.2 |
D(3) : | 27.5 |
| RSI | RSI(14): 38.9 |
|||
| 52-week | High : | 13.48 | Low : | 1.02 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AGPU ] has closed above bottom band by 32.1%. Bollinger Bands are 0.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.37 - 8.42 | 8.42 - 8.46 |
| Low: | 7.64 - 7.7 | 7.7 - 7.75 |
| Close: | 7.91 - 8.01 | 8.01 - 8.08 |
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Thu, 29 Oct 2026
Axe Compute Inc. (AGPU) stock price, news, quote and history - Yahoo Finance Australia
Sat, 24 Oct 2026
Axe Compute Inc USD0.01 share price | AGPU - Hargreaves Lansdown
Thu, 17 Sep 2026
Axe Compute Inc. Reports Material Event - Stock Titan
Tue, 18 Aug 2026
Axe Compute Inc (AGPU) (Q2 2026) Earnings Call Highlights: $3 Billion in New Contracts and ... - Yahoo Finance
Tue, 18 Aug 2026
Axe Compute Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AGPU) 2026-08-18 - Seeking Alpha
Fri, 26 Jun 2026
Axe Compute Inc. Actuals & Estimates (NASDAQ:AGPU) - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | -28 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.159e+007 (%) |
| Held by Institutions | 1.122e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 237120 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.64 |
| Profit Margin | 0 % |
| Operating Margin | -539 % |
| Return on Assets (ttm) | -58.5 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 3.26e+006 % |
| Gross Profit (p.s.) | -0.38 |
| Sales Per Share | -281.65 |
| EBITDA (p.s.) | 15132.2 |
| Qtrly Earnings Growth | -4.842e+007 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.58 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 0 |
| Dividend | 665620 |
| Forward Dividend | 605150 |
| Dividend Yield | 8320250% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|